Lifecare ASA (OSL:LIFE) 3-Year RORE % : 11.26% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:LIFE Lifecare ASA OSL:LIFE
8 GF Score
Price kr0.30
GF Value kr0.14
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Lifecare ASA 3-Year RORE %?

Lifecare ASA OSL:LIFE -0.17% 8 3-Year RORE % is 11.26 as of Mar. 2026. GuruFocus rates OSL:LIFE with a GF Score™ of 8/100 and a GF Value™ of kr0.14 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 777 Medical Devices & Instruments companies, Lifecare ASA ranks better than 66.92% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Lifecare ASA's 3-Year RORE % for the quarter that ended in Mar. 2026 was 11.26%.

The industry rank for Lifecare ASA's 3-Year RORE % or its related term are showing as below:

OSL:LIFE's 3-Year RORE % is ranked better than
66.92% of 777 companies
in the Medical Devices & Instruments industry
Industry Median: -4.07 vs OSL:LIFE: 11.26

Lifecare ASA  (OSL:LIFE) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Lifecare ASA 3-Year RORE % Related Terms


Lifecare ASA 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Lifecare ASA's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecare ASA 3-Year RORE % Chart

Lifecare ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.91 0.00 0.00 59.98 31.30

Lifecare ASA Quarterly Data
Jun19 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.87 42.45 42.69 31.30 11.26

OSL:LIFE vs ABT, SYK, MDT: 3-Year RORE % Comparison

For the Medical Devices subindustry, Lifecare ASA's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecare ASA 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Lifecare ASA's 3-Year RORE % falls into.


OSL:LIFE
8GF Score
Lifecare ASA OSL:LIFE
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lifecare ASA 3-Year RORE % Calculation

Lifecare ASA's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -2.094--1.373 )/( -6.402-0 )
=-0.721/-6.402
=11.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 11.26 mean?
Lifecare ASA (OSL:LIFE) has a 3-Year RORE % of 11.26 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Lifecare ASA and its competitors. According to the industry distribution chart, Lifecare ASA ranks #257 out of 777 companies in the Medical Devices & Instruments industry, placing it in the top 33.1%.
Is Lifecare ASA's 3-Year RORE % too high?
Lifecare ASA's current 3-Year RORE % is 11.26. Based on the distribution chart, Lifecare ASA ranks #257 out of 777 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lifecare ASA has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lifecare ASA's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lifecare ASA ranks #257 out of 777 companies for 3-Year RORE %. This puts Lifecare ASA in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Lifecare ASA and its competitors. Lifecare ASA's current 3-Year RORE % is 11.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecare ASA stock overvalued right now?
Based on GuruFocus' analysis, Lifecare ASA (OSL:LIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.14, compared to a current price of kr0.30 — trading 111.1% above its estimated fair value. The current 3-Year RORE % is 11.26. Lifecare ASA's overall GF Score™ is 8/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Lifecare ASA (OSL:LIFE), the current 3-Year RORE % is 11.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifecare ASA (OSL:LIFE) Overvalued in 2026?

Based on GuruFocus' analysis, Lifecare ASA stock appears to be overvalued. The current stock price of kr0.30 is trading 111.1% above its estimated GF Value™ of kr0.14. GuruFocus considers Lifecare ASA to be Significantly Overvalued.

Key valuation signals for OSL:LIFE:

  • 3-Year RORE %: 11.26
  • GF Value™: kr0.14 vs. price of kr0.30 (111.1% above fair value)
  • GF Score™: 8/100 with 6 warning signs

No single metric tells the full story. See the OSL:LIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lifecare ASA Business Description

Other Exchanges LFC0:Germany
Address Ytrebygdsvegen 215, Blomsterdalen, Bergen, NOR, 5258
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. It is focused on advancing continuous glucose monitoring systems and uses osmotic pressure as a sensing method. Its technology can be applied to detect and monitor various analytes and molecules in humans and animals. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
8GF Score

Get the complete analysis for OSL:LIFE

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.30
Price
kr0.14
GF Value